CTA Community Poll: How Does Your Work Life Balance Compare to Your Peers?
Over a third of our respondents indicated that their job in oncology allowed them sufficient work/life balance. Surprisingly, only 6% of respondents felt they never experienced a sufficient balance between their home life and work life because of their oncology-related profession.
In this age when technology allows us to be “connected” at almost any time, in any place, we were curious about how many of you actually completely disconnected while you were away from work. About 40% of the CTA poll respondents said that they only occasionally check and respond to email while on vacation.
What does a vacation mean to you these days? Does it just mean time off to recharge, or is it an opportunity to get personal tasks accomplished? One third of CTA poll respondents use their time off to complete tasks they can't get done because of work.
Much has been discussed about “burnout” in the oncology community because of the demands of the job and the emotional and physical stress that can result. Over 38% of poll respondents indicated that their own health and happiness are affected by their work schedule.
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- Breast Implant-Associated Anaplastic Large Cell Lymphoma — In the Clinic
- Immune Checkpoint Inhibitors for NSCLC: Current and Future Approaches
- Can A Consortium of Hospitals Help To Reduce Drug Prices?
- Clostridium Difficile Infection in Patients With Cancer — In the Clinic
- 5α-Reductase Inhibitors Do Not Increase Risk of High-Grade Prostate Cancer
- FDA Approves Front-Line Brentuximab Vedotin Plus Chemotherapy for Hodgkin Lymphoma
- NSCLC: Pretreatment Weight Loss May Be Linked to Socioeconomic Status
- Targeted and Immunotherapies for Metastatic Renal Cell Carcinoma
- Atezolizumab, Carboplatin, Nab-Paclitaxel Combination Prolongs PFS in NSCLC
- Model May Identify Patients With Gastric Cancer Likely To Benefit From Chemotherapy